Company intelligence / Profile preview

Long Grove Pharmaceuticals

Rosemont, Illinois, United Stateslonggrovepharma.com ↗

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Long Grove Pharmaceuticals develops and commercializes differentiated complex generic pharmaceuticals with a focus on ready-to-use injectable premixes for critical care. Their recent launches include premix vasopressin and norepinephrine in sodium chloride solution. The company's approach leverages in-house R&D supported by Capstone Development Services and partnerships with global manufacturers to address supply chain reliability for U.S. hospitals. They have rapidly brought several products to market since their first launch in 2022.

Therapeutic areas: Metabolic DisordersOphthalmologyCardiovascularOncologyOtherWomen's Health
Modalities: Small moleculeBiologic (for some injectables)Injectable drug products
Industry: Biotech

Partnerships

Partnerships with well-established global manufacturersCapstone Development Services

Beyond the preview

Go deeper on Long Grove Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long Grove Pharmaceuticals.

Explore the full profile